https://en.bharatpedia.org/w/index.php?action=history&feed=atom&title=Strides_Pharma_ScienceStrides Pharma Science - Revision history2026-08-20T00:03:32ZRevision history for this page on the wikiMediaWiki 1.43.6https://en.bharatpedia.org/w/index.php?title=Strides_Pharma_Science&diff=537671&oldid=prevSerzude: Put Up Basic Entry Initial Version2024-12-10T20:57:38Z<p>Put Up Basic Entry Initial Version</p>
<p><b>New page</b></p><div>{{Short description|Indian pharmaceutical company}}<br />
{{Use dmy dates|date=August 2018}}<br />
{{Use Indian English|date=August 2018}}<br />
{{more citations needed|date=December 2024}}<br />
{{Infobox company<br />
| name = Strides Pharma Science<br />
| logo = Strideslogofinalsmall.svg<br />
| traded_as = {{NSE|STRIDES}}<br>{{BSE|532531}}<br />
| image = StridesHQStar1.svg<br />
| type = [[Public company|Public]]<br />
| foundation = 1990<br />
| location = [[Bannerghatta Road]], [[Bangalore]], India<br />
| key_people = Arun Kumar (Founder and Chairman)<br />
| industry = [[Pharmaceutical]]<br />
| products = Hard gelatin, solid dosage, Tablets, Formulations<br />
| revenue = {{profit}} $566 million (2014)<ref>{{Cite web | url=http://www.stridesarco.com/pdf/financial/annual/Strides_Arcolab_Annual_Report_2013-14.pdf | title=Strategy to delivery | archive-url=https://web.archive.org/web/20150404053935/http://www.stridesarco.com/pdf/financial/annual/Strides_Arcolab_Annual_Report_2013-14.pdf | archive-date=2015-04-04}}</ref><br />
| operating_income = <br />
| net_income = <br />
| num_employees = <br />
| parent = <br />
| subsid = <br />
| homepage = {{url|www.strides.com}}<br />
| footnotes = <br />
}}<br />
<br />
'''Strides Pharma Science Limited''' is an Indian [[pharmaceutical]] company, headquartered at [[Bangalore]]. The company manufactures pharmaceutical products, [[over-the-counter drug]]s and [[nutraceutical]]s. Products include [[softgel]] capsules, hard-gel capsules, tablets and dry and wet [[injectable]]s. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies{{which|date=October 2014}} to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the [[Bombay Stock Exchange]] and on the [[National Stock Exchange of India]].<br />
<br />
'''Strides Arcolab''' changed name to '''Strides Shasun Ltd''' after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab.<ref>{{cite news | url=https://www.business-standard.com/article/pti-stories/strides-arcolab-changes-name-to-strides-shasun-ltd-115111900542_1.html | title=Strides Arcolab changes name to Strides Shasun Ltd | date=19 November 2015 | author=PTI | newspaper=Business Standard | access-date=6 August 2018 }}</ref> In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.<ref>[http://www.thehindu.com/business/Industry/shasun-pharmaceuticals-to-merge-with-strides-arcolab/article6458529.ece Shasun Pharmaceuticals to merge with Strides Arcolab]</ref><br />
<br />
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception.<ref>[http://businesstoday.intoday.in/story/best-indian-ceos-2014-arun-kumar-strides-arcolab-pharma/1/212734.html Arun Kumar aims to reinvent Strides Arcolab with eye on new opportunities]</ref><br />
<br />
==Manufacturing==<br />
=== Indian plants ===<br />
In India the company operates eight pharmaceutical plants:<br />
<br />
*''KRSG Anekal'' - The company has a manufacturing plant at Jigani in the taluka of [[Anekal]] in the southern part of the Bangalore metropolitan area. The plant makes soft gelatin capsules, hard gelatin capsules, tablets and ointments.<br />
*''STAR - Strides Technology & Research'' - the R&D centre at Bannerghata Road (opp. [[Indian Institute of Management Bangalore|IIM-B]], Bangalore)<br />
On 5 December 2013, the company announced that it had completed the sale of its Agila Specialties Division to [[Mylan]] Inc., for a total sum of up to US$1.75 billion.{{citation needed|date=October 2014}}<br />
<br />
=== Non-Indian plants ===<br />
*''Europe'' - Italy (Beltapharm S.pA)<br />
<br />
== Global Disease Initiative ==<br />
Strides operates in the international market for generics to fight HIV/ AIDS, TB and malaria. The company works with the [[Clinton Foundation]] to supply lower cost [[anti-retroviral]] drugs for the treatment of [[HIV/AIDS]] as part of the Clinton Foundation's HIV/AIDS initiative. The company is also on the list of [[World Health Organization]] pre-qualified suppliers to supply generic fixed dose combination of anti-HIV drugs. It is an approved supplier to the [[World Bank]], the [[African Development Bank]], PEPFAR [[President's Emergency Plan For AIDS Relief]] and [[UNICEF]].<br />
<br />
==References==<br />
{{reflist}}<br />
<br />
==External links==<br />
* {{Official website|www.strides.com}}<br />
<br />
[[Category:Pharmaceutical companies of India]]<br />
[[Category:Companies listed on the Bombay Stock Exchange]]<br />
[[Category:Companies listed on the National Stock Exchange of India]]<br />
[[Category:Companies based in Bengaluru]]<br />
[[Category:Pharmaceutical companies established in 1990]]</div>Serzude